Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

70.86
BATS BZX Real-Time Price
As of 2:13pm ET
 -0.24 / -0.34%
Today’s Change
50.90
Today|||52-Week Range
85.83
-5.05%
Year-to-Date
Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says
Sep 26 / TheStreet.com - Paid Partner Content
10 Stocks David Dreman Is Buying
Sep 21 / GuruFocus News - Paid Partner Content
Andrew Left Says Trump and Clinton Agree on Just One Thing
Sep 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close71.10
Today’s open71.40
Day’s range70.15 - 72.48
Volume96,462
Average volume (3 months)1,614,548
Market cap$7.7B
Dividend yield--
Data as of 2:13pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+6.77%
Earnings growth (next 5 years)+9.08%
Revenue growth (last year)+31.75%
P/E ratio15.4
Price/Sales2.40
Price/Book1.56

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+0.70+0.57%
SGENSeattle Genetics Inc+0.61+1.09%
ALKSAlkermes Plc+0.73+1.50%
RDYDr.Reddy's Laborator...+0.38+0.80%
Data as of 2:15pm ET, 09/27/2016

Financials

Next reporting dateNovember 16, 2016
EPS forecast (this quarter)$1.99
Annual revenue (last year)$3.3B
Annual profit (last year)$322.1M
Net profit margin9.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts

Search for Jobs